UBS Group AG - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,284
+214.2%
5,561
+213.1%
0.00%
Q2 2022$2,000
-75.0%
1,776
-10.7%
0.00%
Q3 2021$8,000
+166.7%
1,988
+98.8%
0.00%
Q2 2021$3,000
-78.6%
1,000
-84.5%
0.00%
Q1 2021$14,000
-73.6%
6,454
-72.6%
0.00%
Q4 2020$53,000
+562.5%
23,568
+686.6%
0.00%
Q3 2020$8,000
-78.9%
2,996
-75.8%
0.00%
Q2 2020$38,000
-22.4%
12,401
-50.4%
0.00%
Q1 2020$49,000
-66.7%
25,009
-51.3%
0.00%
Q4 2019$147,000
+19.5%
51,319
+53.5%
0.00%
Q3 2019$123,000
+64.0%
33,428
+84.9%
0.00%
Q2 2019$75,000
+120.6%
18,080
+168.9%
0.00%
Q1 2019$34,000
+9.7%
6,724
-26.2%
0.00%
Q4 2018$31,000
+158.3%
9,106
+365.8%
0.00%
Q3 2018$12,000
-73.9%
1,955
-72.9%
0.00%
Q2 2018$46,000
+58.6%
7,201
+17.6%
0.00%
Q1 2018$29,000
+107.1%
6,122
-7.8%
0.00%
Q3 2017$14,000
+133.3%
6,643
+175.3%
0.00%
Q2 2017$6,000
-33.3%
2,413
-34.9%
0.00%
Q1 2017$9,000
+800.0%
3,705
+340.5%
0.00%
Q4 2016$1,000
-88.9%
841
-85.8%
0.00%
Q2 2016$9,0005,936
+6495.6%
0.00%
Q1 2016$0900.0%0.00%
Q4 2015$0
-100.0%
90
-97.0%
0.00%
Q3 2015$7,000
+16.7%
2,957
+40.0%
0.00%
Q2 2015$6,0000.0%2,112
+31.3%
0.00%
Q1 2015$6,000
-50.0%
1,608
-54.2%
0.00%
Q4 2014$12,0003,5140.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders